Education
About Us
Working with TipRanks
Follow Us
Jeffrey Stein Insider Profile
25 Followers
Jeffrey Stein, President & CEO, Director at Cidara Therapeutics, holds 0.00 shares in Cidara Therapeutics (Ticker: CDTX), holds 0.00 shares in Paratek Pharmaceuticals (Ticker: PRTK), holds ― shares in IDEAYA Biosciences (Ticker: IDYA). Most recently, Jeffrey Stein Bought ― shares of Cidara Therapeutics on Jan 07, 2026 for an estimated value of $339.02K.
Jeffrey Stein Cidara Therapeutics (CDTX)President & CEO, Director
Cidara Therapeutics (CDTX)
President & CEO, Director
Ranked #86,340 out of 106,013 Corporate Insiders
Profitable Transactions
2 out of 11 Profitable Transactions
Average Return
-14.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Jeffrey Stein does not currently own shares as a corporate insider.
A breakdown of Jeffrey Stein's holdings
Insider Roles
Director
Roles that Jeffrey Stein holds in companies
Most Profitable Insider Trade
Stock:
Cidara Therapeutics
(CDTX)
(CDTX)
Rating:Informative Buy
Date:Jun 11, 2024 - Jun 11, 2025
Return:+91.30%
The most profitable trade made by Jeffrey Stein
Jeffrey Stein's Trading History
Cidara Therapeutics
Jan 07, 2026
―
Informative Buy
339.02K
$0.00
Paratek Pharmaceuticals
Sep 21, 2023
―
Uninformative Sell
―
$0.00
IDEAYA Biosciences
―
Director
―
―
Trius Therap
Aug 02, 2010
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Jeffrey Stein's performance on stock
You May Also Like
Jeffrey Stein insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Stein?
The percentage of profitable transactions made by Jeffrey Stein is 18%.
What is the average return per transaction made by Jeffrey Stein?
The average return per transaction made by Jeffrey Stein is -14.60%.
What stocks does Jeffrey Stein hold?
Jeffrey Stein holds: CDTX, PRTK, IDYA, TSRX stocks.
What was Jeffrey Stein’s latest transaction?
Jeffrey Stein latest transaction was an Informative Buy of $339.02K.
What was Jeffrey Stein's most profitable transaction?
Jeffrey Stein’s most profitable transaction was an Informative Buy of CDTX stock on June 11, 2024. The return on the trade was 91.30%.
What is Jeffrey Stein's role in Cidara Therapeutics?
Jeffrey Stein's role in Cidara Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.